Sands BE - Search Results

1

LRRK2 is involved in the IFN-gamma response and host response to pathogens.

Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, Podolsky DK. Gardet A, et al. Among authors: sands be. J Immunol. 2010 Nov 1;185(9):5577-85. doi: 10.4049/jimmunol.1000548. Epub 2010 Oct 4. J Immunol. 2010. PMID: 20921534 Free PMC article.

2

Molecular cloning of the rat intestinal trefoil factor gene. Characterization of an intestinal goblet cell-associated promoter.

Sands BE, Ogata H, Lynch-Devaney K, deBeaumont M, Ezzell RM, Podolsky DK. Sands BE, et al. J Biol Chem. 1995 Apr 21;270(16):9353-61. doi: 10.1074/jbc.270.16.9353. J Biol Chem. 1995. PMID: 7721858 Free article.

3

Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion.

Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, DeBeaumont M, Sands BE, Mahida YR. Podolsky DK, et al. Among authors: sands be. J Biol Chem. 1993 Mar 25;268(9):6694-702. J Biol Chem. 1993. PMID: 8454642 Free article.

4

An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele.

Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S. Forcione DG, et al. Proc Natl Acad Sci U S A. 1996 May 14;93(10):5094-8. doi: 10.1073/pnas.93.10.5094. Proc Natl Acad Sci U S A. 1996. PMID: 8643533 Free PMC article.

5

The trefoil peptide family.

Sands BE, Podolsky DK. Sands BE, et al. Annu Rev Physiol. 1996;58:253-73. doi: 10.1146/annurev.ph.58.030196.001345. Annu Rev Physiol. 1996. PMID: 8815795 Review.

6

Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.

Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky DK, Pillai S. Cariappa A, et al. Gut. 1998 Aug;43(2):210-5. doi: 10.1136/gut.43.2.210. Gut. 1998. PMID: 10189846 Free PMC article.

7

New life in a sleeper: thalidomide and Crohn's disease.

Sands BE, Podolsky DK. Sands BE, et al. Gastroenterology. 1999 Dec;117(6):1485-8. doi: 10.1016/s0016-5085(99)70299-4. Gastroenterology. 1999. PMID: 10579990 No abstract available.

8

Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms.

Willett CG, Ooi CJ, Zietman AL, Menon V, Goldberg S, Sands BE, Podolsky DK. Willett CG, et al. Among authors: sands be. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):995-8. doi: 10.1016/s0360-3016(99)00374-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705022

9

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR, Podolsky DK. Sands BE, et al. Inflamm Bowel Dis. 2001 May;7(2):83-8. doi: 10.1097/00054725-200105000-00001. Inflamm Bowel Dis. 2001. PMID: 11383595 Clinical Trial.

10

Infliximab maintenance therapy for fistulizing Crohn's disease.

Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Sands BE, et al. N Engl J Med. 2004 Feb 26;350(9):876-85. doi: 10.1056/NEJMoa030815. N Engl J Med. 2004. PMID: 14985485 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters